An Effective Diagnose for Enhancing Cancer Treatment

An Effective Diagnose for Enhancing Cancer Treatment

Alex D'Souza, Healthcare Tech Outlook | Tuesday, August 09, 2022

Cancer is emerging as a major threat in the 21st century due to the modernised and unhealthy lifestyle that people have begun to adapt to. Hence, the European oncology market has come up with cutting-edge innovations to control the cancer mortality rate.

FREMONT, CA: The number of elderly people receiving special health care has increased substantially in recent times. As people aged 65 and above are exposed to a high risk of developing cancer ailments at a high rate, regular health checkups have become a part of their daily lives. In addition to this, factors such as excessive alcohol, tobacco, smoking, and unhealthy dietary habits have adverse effects on people’s lives by increasing the number of cancer patients. Thus, to tackle this catastrophe, the governments of European countries take initiatives by launching campaigns preaching the advantages of early diagnosis and treatment for cancer.

The Europe oncology market may likely reach 119.5 billion USD by 2028. The advancement of medical device technology has aided the cancer diagnostic segment, which accounted for nearly 45.4 percent of the European oncology market in 2021. With the help of these machines, the exact tumour location is detected and an effective treatment for the same is planned. Alongside, companies are piling up with new innovations in cancer devices which, in turn, enhance the accuracy of cancer detection and build the mileage of these devices among medical end-users.

Furthermore, there is an increased elevation of prostate cancer cases. It is most likely due to unhealthy lifestyle choices like tobacco, smoking, and alcohol consumption, as well as family history, obesity, old age, and sedentary lifestyle. Hence, the prostate cancer segment is expected to reach USD 12.1 billion in the regional industry by 2028. A report from WHO demonstrated that Germany accounted for the highest number of prostate cancer cases, nearly 10.8 per cent in 2020. This has prompted organisations to boost the efficiency and accuracy of diagnostic and imaging devices for reducing cancer.

The European oncology diagnostic laboratories market will grow at an 8.5 percent CAGR (Compound Annual Growth Rate) between 2022 and 2028.These labs provide testing facilities, tumour biopsy and imaging scans with diagnostic laboratories where skilled medical professionals and technicians carry out the testing processes. This, however, increases the preference for diagnostic laboratories among healthcare workers.

France is witnessing a fuming increase with the number of cancer cases increasing. In 2020, 467,965 new cancer cases were reported in France. With these serious statistics, technologically advanced medical devices and treatments can be facilitated for enhancing patients’ quality of life and increasing their survival rate.

Weekly Brief